Envestnet Portfolio Solutions Inc. Trims Stock Position in Stericycle, Inc. (NASDAQ:SRCL)

Envestnet Portfolio Solutions Inc. cut its holdings in shares of Stericycle, Inc. (NASDAQ:SRCL) by 10.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 6,597 shares of the business services provider’s stock after selling 784 shares during the quarter. Envestnet Portfolio Solutions Inc.’s holdings in Stericycle were worth $327,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in SRCL. Arizona State Retirement System raised its holdings in shares of Stericycle by 1.4% in the 3rd quarter. Arizona State Retirement System now owns 26,322 shares of the business services provider’s stock worth $1,177,000 after purchasing an additional 358 shares during the period. Equitable Trust Co. raised its holdings in shares of Stericycle by 8.7% in the 3rd quarter. Equitable Trust Co. now owns 6,647 shares of the business services provider’s stock worth $297,000 after purchasing an additional 531 shares during the period. Barclays PLC raised its holdings in shares of Stericycle by 30.6% in the 3rd quarter. Barclays PLC now owns 70,408 shares of the business services provider’s stock worth $3,147,000 after purchasing an additional 16,505 shares during the period. Impax Asset Management Group plc raised its holdings in shares of Stericycle by 2.3% in the 3rd quarter. Impax Asset Management Group plc now owns 2,991,580 shares of the business services provider’s stock worth $132,805,000 after purchasing an additional 66,746 shares during the period. Finally, Robeco Schweiz AG raised its holdings in shares of Stericycle by 17.6% in the 3rd quarter. Robeco Schweiz AG now owns 1,019,692 shares of the business services provider’s stock worth $45,590,000 after purchasing an additional 152,780 shares during the period. 98.82% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

SRCL has been the topic of several analyst reports. Robert W. Baird dropped their target price on Stericycle from $62.00 to $55.00 and set a “neutral” rating on the stock in a report on Friday, April 26th. StockNews.com downgraded Stericycle from a “buy” rating to a “hold” rating in a report on Tuesday, April 2nd. Wells Fargo & Company raised their target price on Stericycle from $40.00 to $48.00 and gave the company an “underweight” rating in a report on Friday, March 1st. Truist Financial dropped their target price on Stericycle from $57.00 to $50.00 and set a “hold” rating on the stock in a report on Monday, April 29th. Finally, Stifel Nicolaus raised their target price on Stericycle from $70.00 to $75.00 and gave the company a “buy” rating in a report on Thursday, February 29th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, Stericycle currently has an average rating of “Hold” and an average price target of $59.40.

Stericycle Stock Performance

Shares of NASDAQ SRCL opened at $51.65 on Friday. Stericycle, Inc. has a fifty-two week low of $37.78 and a fifty-two week high of $57.06. The business has a 50 day moving average price of $49.10 and a two-hundred day moving average price of $48.84. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.11 and a current ratio of 1.11.

Stericycle (NASDAQ:SRCL) last issued its quarterly earnings data on Thursday, April 25th. The business services provider reported $0.57 earnings per share for the quarter, beating analysts’ consensus estimates of $0.54 by $0.03. The firm had revenue of $664.90 million during the quarter, compared to analyst estimates of $676.42 million. Stericycle had a positive return on equity of 7.31% and a negative net margin of 0.74%. Stericycle’s quarterly revenue was down 2.8% on a year-over-year basis. During the same quarter last year, the firm earned $0.49 EPS. Sell-side analysts predict that Stericycle, Inc. will post 2.32 EPS for the current fiscal year.

About Stericycle

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.